Kiromic Biopharma, Inc.https://pcaobus.org/form-ap-filings/58253/58253Kiromic Biopharma, Inc.582537/1/2020 9:07:53 PM2019132e592e-c778-41a2-85d0-9f993a2337db34Deloitte & Touche LLP779668Kiromic Biopharma, Inc.1792581KRBP0003411467Emily Reodica Rollins0003411467True
Kiromic Biopharma, Inc.https://pcaobus.org/form-ap-filings/56512/56512Kiromic Biopharma, Inc.565125/15/2020 2:57:42 PM201963c58f69-0684-4b91-bde4-cdbcfeee321134Deloitte & Touche LLP779668Kiromic Biopharma, Inc.1792581KRBP0003411467Emily Reodica Rollins0003411467True
Nuvectra Corphttps://pcaobus.org/form-ap-filings/34741/34741Nuvectra Corp347413/12/2019 11:49:58 PM2018e007ba3d-0163-4eb4-8ff5-c8336334864634Deloitte & Touche LLP625307Nuvectra Corp1648893NVTRQ0003411467Emily Reodica Rollins0003411467True
Nuvectra Corphttps://pcaobus.org/form-ap-filings/19925/19925Nuvectra Corp199253/21/2018 6:47:28 PM20171f165492-e0bf-480d-a84c-8e97a9f41f7534Deloitte & Touche LLP625307Nuvectra Corp1648893NVTRQ0003411467Emily Reodica Rollins0003411467True
Nuvectra Corphttps://pcaobus.org/form-ap-filings/5561/5561Nuvectra Corp55614/6/2017 4:15:27 PM2016e4fe9d20-3df5-40e9-8c10-dba6d328cc0934Deloitte & Touche LLP625307Nuvectra Corp1648893NVTRQ0003411467Emily Reodica Rollins0003411467True